POCN Facebook ad: “See real-world survey results”

Ran for 28 days, from February 11 to March 11, 2026, the last day Crush saw it.
Run by POCN on Instagram. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 889892347083035
- Platforms
- Instagram and Threads
- Relaunches
- 0
Ad text
Please see full Prescribing Information, including Boxed Warning, for AUSTEDO XR® (deutetrabenazine) extended-release tablets at @austedopi. Interested in real-world survey results from patients taking AUSTEDO XR?
Where the ad sends people
go.pointofcarenetwork.com
See real-world survey results
Did you know that TD is commonly impairing, yet often untreated? For that reason, it is important to treat your patients who have TD movements with a VMAT2 inhibitor like AUSTEDO XR.1-4
Learn more: go.pointofcarenetwork.com(opens in a new tab)









